Bipolar Medications and Weight Gain

Several of the most effective bipolar medications can cause weight gain, and for many people it is the side effect that matters most. The good news is that the medications differ a lot, monitoring can catch changes early, and there are options short of stopping treatment. This page looks at weight through a bipolar lens: which mood stabilizers and antipsychotics are more or less likely to cause gain according to their labels and the research, why metabolic health deserves extra attention in bipolar disorder, and how to raise the issue without putting your stability at risk.

Why weight matters more in bipolar disorder

Weight is not only about appearance. The VA/DoD guideline notes that bipolar disorder is associated with roughly 10 years of potential life lost, and that about half of people with bipolar disorder smoke, both of which point to heart and metabolic disease. Medication-related weight gain adds to that baseline risk.

That is why NICE recommends an annual physical health check for everyone with bipolar disorder (weight or BMI, diet, activity, blood pressure, glucose or HbA1c and lipids), not only for people taking an antipsychotic. Treating weight as part of bipolar care, rather than a cosmetic complaint, is the integrative way to look at it.

Mood stabilizers: from weight-neutral to weight-gaining

So among mood stabilizers, lamotrigine is the one most often described as weight-neutral, but it has a narrower role: it is FDA-approved for bipolar I maintenance and is not used for acute mania. That trade-off is why the most weight-friendly option is not automatically the right one. For the drugs in detail, see lamotrigine and lithium.

Antipsychotics: the biggest differences

Every atypical antipsychotic label carries a metabolic warning, but the size of the effect varies widely. A 2020 network meta-analysis of 100 trials (in schizophrenia, where most comparative data exist) found olanzapine and clozapine had the least favorable metabolic profiles and aripiprazole, brexpiprazole, cariprazine, lurasidone and ziprasidone the most favorable. Our general guide to weight gain on psychiatric medication has a class-by-class table; here is what the bipolar labels add:

• olanzapine: the label says weight gain was clinically significant across all starting BMI categories and that adolescents gain more, which may lead clinicians to consider other drugs first in teens.
• quetiapine: weight gain is among the most common side effects in adult trials, and in children the label says gain should be judged against normal growth.
• lurasidone: in teens aged 10–17 with bipolar depression, weight increase was among the most common side effects.
• cariprazine: in a long-term open-label study of young people with bipolar I mania, no participant stopped because of weight increase.

For phase-by-phase approvals and other side effects, see atypical antipsychotics in bipolar disorder.

Weight changes that are not side effects

Not all weight change comes from the pill. Bipolar episodes themselves change appetite and activity: depression can bring overeating, oversleeping and low activity, and mania often brings weight loss from little sleep and constant movement. After an episode settles, some weight may return simply because eating and sleeping have normalized.

A clear timeline helps sort this out: your usual weight before you became unwell, during the worst of the episode, and since each medication started or changed. Bring it to your appointment, along with notes on hunger, cravings, sleep and activity.

Monitoring that catches changes early

Early gain is easier to address than gain that has built up over a year. NICE CG185 sets out monitoring for people starting an antipsychotic: weight weekly for the first 6 weeks, then at 12 weeks, with glucose or HbA1c and lipids at 12 weeks and at least yearly after that. For anyone with bipolar disorder, it adds the annual check described above.

Waist size and blood results matter as well as the scale, because blood sugar and lipids can change before much weight is gained. Our guide to lab work in bipolar care explains which tests go with which medication.

Raising weight gain without risking relapse

Stopping a mood stabilizer or antipsychotic suddenly can bring back mania or depression. If weight is a problem, say so; it is a legitimate reason to revisit treatment. Options a prescriber may discuss include reviewing the dose, switching to a lower-risk drug when your history allows it, adding lifestyle support early, and, for antipsychotic-related gain, adding a medication; the general weight gain page covers those options and their evidence.

A switch is weighed against the risk of losing stability. For someone whose bipolar I has been steady on a weight-gaining drug for years, the safest path may be to manage the weight rather than change the medication.

Food, movement and sleep that support stability

Lifestyle steps do not need to be extreme to help, and many of them support mood as well: regular meal times, protein and fiber to blunt cravings, cutting back on sugary drinks (worth noting with lithium-related thirst), daily movement you can keep up, and a steady sleep schedule. NIMH advises keeping a routine for eating, sleeping and exercise. Our page on the bipolar diet covers food in more detail. Avoid crash diets and appetite-suppressing supplements without checking with your prescriber, since dehydration and some supplements can interact with bipolar medications.

Questions to bring to your appointment

• How much weight change is typical with this medication, and when does it usually show up?
• Which numbers will we track besides weight: waist, blood pressure, glucose or HbA1c, lipids?
• If I gain weight, what would we try first, and what would make a switch worth the risk?
• Could my thyroid, my sleep or another medication be contributing?
• Is there an option with less metabolic risk that still covers the phase I need treated?

Writing down your weight, waist size and sleep for a few weeks before the visit makes these questions easier to answer. If you have a family history of diabetes or heart disease, mention it; it can shift which medication makes the most sense from the start.

At Willow & Stone

At Willow & Stone, weight, metabolic health and mood are reviewed together as part of medication management, and labs are ordered as needed. Read about bipolar disorder treatment at Willow & Stone or return to the bipolar disorder guide.

Common Questions

Sources & Further Reading

• Pillinger et al.: Metabolic effects of 18 antipsychotics, network meta-analysis (Lancet Psychiatry, 2020)
• NICE CG185: Bipolar disorder: assessment and management (last updated 2 Sept 2025)
• VA/DoD Clinical Practice Guideline for the Management of Bipolar Disorder (Version 2.0, 2023)
• DailyMed: Lamictal (lamotrigine) prescribing information (10/2025)
• DailyMed: Lithium carbonate prescribing information (4/2026)
• DailyMed: Depakote (divalproex) prescribing information (3/2026)
• DailyMed: Latuda (lurasidone) prescribing information

This article is general education, not a diagnosis or advice for your situation. Do not start, stop, or change a medication without talking to the clinician who prescribes it; stopping a mood stabilizer suddenly can trigger relapse.